This result suggests that TGFβ is possibly regulated by the same mechanism, involving constitutive activation of KRAS oncogene during carcinogenesis of both pancreatic adenocarcinoma and MDB. The gene discussed is KRAS; the disease is pancreatic adenocarcinoma.